Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells

被引:22
作者
Chu, Carolyn [1 ]
Armenia, Daniele [2 ]
Walworth, Charles [3 ]
Santoro, Maria M. [4 ]
Shafer, Robert W. [5 ]
机构
[1] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA
[2] St Camillus Int Univ Hlth Sci, UniCamillus, Rome, Italy
[3] Lab Corp Monogram Biosci, South San Francisco, CA USA
[4] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[5] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
关键词
antiviral therapy; DNA sequencing; HIV-1; peripheral blood mononuclear cells; provirus; adaptive mutations; drug resistance evolution; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; RILPIVIRINE/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE; DRUG-RESISTANCE; HIV-1-INFECTED PATIENTS; PROVIRAL DNA; LATENT RESERVOIR; TREATMENT INTERRUPTION; VIROLOGICAL FAILURE;
D O I
10.1128/cmr.00052-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HIV-1 DNA exists in nonintegrated linear and circular episomal forms and as integrated proviruses. In patients with plasma viremia, most peripheral blood mononuclear cell (PBMC) HIV-1 DNA consists of recently produced nonintegrated virus DNA while in patients with prolonged virological suppression (VS) on antiretroviral therapy (ART), most PBMC HIV-1 DNA consists of proviral DNA produced months to years earlier. Drug-resistance mutations (DRMs) in PBMCs are more likely to coexist with ancestral wild-type virus populations than they are in plasma, explaining why next-generation sequencing is particularly useful for the detection of PBMC-associated DRMs. In patients with ongoing high levels of active virus replication, the DRMs detected in PBMCs and in plasma are usually highly concordant. However, in patients with lower levels of virus replication, it may take several months for plasma virus DRMs to reach detectable levels in PBMCs. This time lag explains why, in patients with VS, PBMC genotypic resistance testing (GRT) is less sensitive than historical plasma virus GRT, if previous episodes of virological failure and emergent DRMs were either not prolonged or not associated with high levels of plasma viremia. Despite the increasing use of PBMC GRT in patients with VS, few studies have examined the predictive value of DRMs on the response to a simplified ART regimen. In this review, we summarize what is known about PBMC HIV-1 DNA dynamics, particularly in patients with suppressed plasma viremia, the methods used for PBMC HIV-1 GRT, and the scenarios in which PBMC GRT has been used clinically. HIV-1 DNA exists in nonintegrated linear and circular episomal forms and as integrated proviruses. In patients with plasma viremia, most peripheral blood mononuclear cell (PBMC) HIV-1 DNA consists of recently produced nonintegrated virus DNA while in patients with prolonged virological suppression (VS) on antiretroviral therapy (ART), most PBMC HIV-1 DNA consists of proviral DNA produced months to years earlier.
引用
收藏
页数:30
相关论文
共 238 条
[21]   Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy [J].
Bi, Xiuqiong ;
Gatanaga, Hiroyuki ;
Koike, Kazuhiko ;
Kimura, Satoshi ;
Oka, Shinichi .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (01) :43-50
[22]   Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year [J].
Bi, XQ ;
Gatanaga, H ;
Ida, S ;
Tsuchiya, K ;
Matsuoka-Aizawa, S ;
Kimura, S ;
Oka, S .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (01) :1-6
[23]   Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection [J].
Blankson, JN ;
Finzi, D ;
Pierson, TC ;
Sabundayo, BP ;
Chadwick, K ;
Margolick, JB ;
Quinn, TC ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1636-1642
[24]  
Blick G., 2021, 18 EUROPEAN AIDS C
[25]   Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study [J].
Boillat-Blanco, Noemie ;
Darling, Katharine E. A. ;
Schoni-Affolter, Franziska ;
Vuichard, Danielle ;
Rougemont, Mathieu ;
Fulchini, Rosamaria ;
Bernasconi, Enos ;
Aouri, Manel ;
Clerc, Olivier ;
Furrer, Hansjakob ;
Gunthard, Huldrych F. ;
Cavassini, Matthias .
ANTIVIRAL THERAPY, 2015, 20 (02) :165-175
[26]   Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients [J].
Bon, Isabella ;
Gibellini, Davide ;
Borderi, Marco ;
Alessandrini, Federica ;
Vitone, Francesca ;
Schiavone, Pasqua ;
Re, Maria Carla .
JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (04) :313-320
[27]   Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice [J].
Borghetti, Alberto ;
Giacomelli, Andrea ;
Borghi, Vanni ;
Ciccullo, Arturo ;
Dusina, Alex ;
Fabbiani, Massimiliano ;
Rusconi, Stefano ;
Zazzi, Maurizio ;
Mussini, Cristina ;
Di Giambenedetto, Simona .
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07)
[28]   Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice [J].
Borghetti, Alberto ;
Lombardi, Francesca ;
Gagliardini, Roberta ;
Baldin, Gianmaria ;
Ciccullo, Arturo ;
Moschese, Davide ;
Emiliozzi, Arianna ;
Belmonti, Simone ;
Lamonica, Silvia ;
Montagnani, Francesca ;
Visconti, Elena ;
De Luca, Andrea ;
Di Giambenedetto, Simona .
BMC INFECTIOUS DISEASES, 2019, 19 (1)
[29]   Multiple Origins of Virus Persistence during Natural Control of HIV Infection [J].
Boritz, Eli A. ;
Darko, Samuel ;
Swaszek, Luke ;
Wolf, Gideon ;
Wells, David ;
Wu, Xiaolin ;
Henry, Amy R. ;
Laboune, Farida ;
Hu, Jianfei ;
Ambrozak, David ;
Hughes, Marybeth S. ;
Hoh, Rebecca ;
Casazza, Joseph P. ;
Vostal, Alexander ;
Bunis, Daniel ;
Nganou-Makamdop, Krystelle ;
Lee, James S. ;
Migueles, Stephen A. ;
Koup, Richard A. ;
Connors, Mark ;
Moir, Susan ;
Schacker, Timothy ;
Maldarelli, Frank ;
Hughes, Stephen H. ;
Deeks, Steven G. ;
Douek, Daniel C. .
CELL, 2016, 166 (04) :1004-1015
[30]   Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads [J].
Boukli, Narjis ;
Boyd, Anders ;
Collot, Marianne ;
Meynard, Jean-Luc ;
Girard, Pierre-Marie ;
Morand-Joubert, Laurence .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) :3129-3136